SEC Filing Summary: Midstates Petroleum Company, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Midstates Petroleum Company, Inc. on April 3, 2015, reporting an event that occurred on April 1, 2015. The filing addresses a regulatory notice received from the New York Stock Exchange (NYSE) regarding the company's stock listing status.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the market price of the company's common stock, which has fallen below the NYSE continued listing standard of $1.00 per share average closing price over 30 consecutive trading days.
Material Changes
The primary material change is the receipt of a formal notice from the NYSE indicating noncompliance with continued listing standards due to the low stock price. This represents a significant shift in the company's regulatory standing and market access status.
Outlook, Risks, and Contingencies
The company intends to cure the deficiency within a six-month period following the notice. To avoid delisting, the stock must close at or above $1.00 on the last trading day of any calendar month within this period, with an average closing price of at least $1.00 over the preceding 30 trading days.
Management highlights several risks if delisting occurs:
- Reduced liquidity and market price of common stock.
- Decreased investor interest, negatively impacting the ability to raise equity financing.
- Limited ability to use registration statements to offer freely tradable securities, restricting access to public capital markets.
- Impaired ability to provide equity incentives to employees.
During the cure period, the stock will remain listed on the NYSE, subject to compliance with other listing requirements.
Investor Verification Checklist
- Verify the current closing price and 30-day average closing price of Midstates Petroleum Company, Inc. stock.
- Monitor the company's progress toward meeting the $1.00 threshold within the six-month cure period.
- Review the press release dated April 3, 2015 (Exhibit 99.1) for additional management commentary.
- Assess the company's capital raising capabilities given the potential threat of delisting.